Topic: GlaxoSmithKline plc

Diversified healthcare giant Novartis (NYSE:NVS) reported impressive 2011 results in January 2012. These strong trends are not projected to carry...
Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly...
GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will stand down from the...
U.S. vaccine advisers on Tuesday voted to recommend that boys be routinely vaccinated with Merck & Co's Gardasil vaccine to protect them from human ...
LEADING figures from the biotechnology sector are to speak at this year's BioWales conference in Cardiff.. . The event, to be held at the Wales ...

Verastem IPO Looks Like Risky Bet

NEW YORK (TheStreet -- Verastem (VSTM) hasn't tried its cancer drugs on any humans yet, but the company is hoping that won't stop investors from...

Over 55s More Active Than Younger People

Editor's Choice According to survey by GlaxoSmithKline (GSK), individuals aged 55+ are more active than the younger generation. Results from the...
By Andrew Jack in London Medical companies are braced for a series of costly settlements this year over actions brought by US agencies for alleged...
BY SCOTT THURM Longtime employees of Stiefel Laboratories Inc. once compared the drug maker to an extended family, with CEOs hosting company...
Analysts at Summer Street Research started coverage on shares of Ligand Pharmaceutica (NASDAQ: LGND) in a research report issued to clients and...